Rhonda Cooper-DeHoff, PharmD
Dr. Cooper-DeHoff is Associate Director of the Center for Pharmacogenomics and Associate Professor in the Department of Pharmacotherapy and Translational Research and the Department of Pharmaceutics, College of Pharmacy, and in the Division of Cardiovascular Medicine, College of Medicine, at the University of Florida.
- 2009 – Research featured by the American Society of Hypertension
- 2008 – Received the Clinical Science Award from the Consortium for Southeastern Hypertension Control
- 2007 – Named Fellow of the American Heart Association
|PharmD||University of California at San Francisco, School of Pharmacy||Pharmacy|
|MS||University of Florida||Medical Sciences/Clinical Investigation|
Dr. Cooper-DeHoff’s research interests include hypertension, metabolic syndrome, and diabetes, and she is the principal investigator for the NIH-funded Career Development Award (K23) entitled “Metabolic Effects of Antihypertensive Drugs.” She was an investigator of the International Verapamil Trandolapril Study (INVEST), which evaluated hypertension treatments in elderly coronary artery disease patients, and is a co-investigator on two NIH grants evaluating pharmacogenetic associations in hypertension. She is a member of the American Heart Association, American Society of Hypertension, American College of Cardiology, and Florida Society of Hospital Pharmacists. Cooper-DeHoff serves as a scientific reviewer for several journals, including Circulation, Annals of Pharmacotherapy, Lancet, and many others.
American Society of Hypertension
American Heart Association
American College of Cardiology
Florida Society of Hospital Pharmacists
North Central Florida Society of Hospital Pharmacists
Please click here for a list of Rhonda Cooper-DeHoff’s industry relationships.